ID: ALA4782057

Max Phase: Preclinical

Molecular Formula: C44H42Cl2N2O7

Molecular Weight: 781.73

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC(=O)c3ccc(Cl)c(Cl)c3)c(OC)cc3c1[C@H](C2)N(C)CC3

Standard InChI:  InChI=1S/C44H42Cl2N2O7/c1-47-16-14-27-22-37(51-4)39-24-31(27)34(47)18-25-6-10-30(11-7-25)53-38-20-26(8-13-36(38)50-3)19-35-41-28(15-17-48(35)2)23-40(52-5)42(43(41)54-39)55-44(49)29-9-12-32(45)33(46)21-29/h6-13,20-24,34-35H,14-19H2,1-5H3/t34-,35-/m0/s1

Standard InChI Key:  ACUPHFVNRCISHM-PXLJZGITSA-N

Associated Targets(Human)

HEL 6614 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 781.73Molecular Weight (Monoisotopic): 780.2369AlogP: 9.68#Rotatable Bonds: 5
Polar Surface Area: 78.93Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.26CX LogP: 9.51CX LogD: 8.29
Aromatic Rings: 5Heavy Atoms: 55QED Weighted: 0.13Np Likeness Score: 1.09

References

1. Yang J,Hu S,Wang C,Song J,Chen C,Fan Y,Ben-David Y,Pan W.  (2020)  Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.,  186  [PMID:31784186] [10.1016/j.ejmech.2019.111898]

Source